Beam Therapeutics Announces CFO Terry-Ann Burrell’s Resignation
PremiumCompany AnnouncementsBeam Therapeutics Announces CFO Terry-Ann Burrell’s Resignation
12d ago
Beam Therapeutics Announces Transition of Chief Financial Officer
PremiumPress Releases
Beam Therapeutics Announces Transition of Chief Financial Officer
12d ago
Beam Therapeutics CFO Terry-Ann Burrell stepping down August 9
PremiumThe Fly
Beam Therapeutics CFO Terry-Ann Burrell stepping down August 9
12d ago
Beam Therapeutics reports data from BEAM-101 trial
PremiumThe FlyBeam Therapeutics reports data from BEAM-101 trial
1M ago
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investigational Base Editing Therapeutic for Sickle Cell Disease
PremiumPress Releases
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investigational Base Editing Therapeutic for Sickle Cell Disease
1M ago
Beam Therapeutics to Participate in Jefferies Global Healthcare Conference
PremiumPress Releases
Beam Therapeutics to Participate in Jefferies Global Healthcare Conference
2M ago
Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call
PremiumThe FlyCantor Fitzgerald healthcare analysts hold an analyst/industry conference call
3M ago
Beam Therapeutics Stock (NASDAQ:BEAM): Investing in Cutting-Edge Gene Editing
PremiumMarket News
Beam Therapeutics Stock (NASDAQ:BEAM): Investing in Cutting-Edge Gene Editing
3M ago
Citi sees limited readthrough for Beam Therapeutics from VERVE-101 trial pause
PremiumThe Fly
Citi sees limited readthrough for Beam Therapeutics from VERVE-101 trial pause
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100